Novo Nordisk enhanced changed operating revenue by 10 % in local currencies in … Operating earnings reduced by 10 % reported in regional currencies and by 11 % in Danish kroner to DKK 12.3 billion. Adjusted for the non-recurring income related to the partial divestment of NNIT and the income related to out-licensing of assets for … Find out more …
Read More »